MA52960A - Compositions et procédés pour la réduction ou le traitement de la fibrose - Google Patents
Compositions et procédés pour la réduction ou le traitement de la fibroseInfo
- Publication number
- MA52960A MA52960A MA052960A MA52960A MA52960A MA 52960 A MA52960 A MA 52960A MA 052960 A MA052960 A MA 052960A MA 52960 A MA52960 A MA 52960A MA 52960 A MA52960 A MA 52960A
- Authority
- MA
- Morocco
- Prior art keywords
- fibrosis
- compositions
- reduction
- treatment
- methods
- Prior art date
Links
- 206010016654 Fibrosis Diseases 0.000 title 1
- 230000004761 fibrosis Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862687718P | 2018-06-20 | 2018-06-20 | |
| US201862758174P | 2018-11-09 | 2018-11-09 | |
| US201962794154P | 2019-01-18 | 2019-01-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52960A true MA52960A (fr) | 2021-04-28 |
Family
ID=67253997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052960A MA52960A (fr) | 2018-06-20 | 2019-06-19 | Compositions et procédés pour la réduction ou le traitement de la fibrose |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210275480A1 (fr) |
| EP (1) | EP3810272A1 (fr) |
| JP (1) | JP2021527669A (fr) |
| CN (1) | CN112839708A (fr) |
| MA (1) | MA52960A (fr) |
| WO (1) | WO2019246298A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| WO2019246201A1 (fr) | 2018-06-20 | 2019-12-26 | Axcella Health Inc. | Procédés de fabrication de compositions d'acides aminés |
| US11737999B2 (en) | 2021-07-26 | 2023-08-29 | Axcella Health Inc. | Amino acid compositions and methods for the treatment of post-acute sequelae of COVID-19 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
| US9884899B2 (en) * | 2007-07-06 | 2018-02-06 | Promedior, Inc. | Methods for treating fibrosis using CRP antagonists |
| KR20090028880A (ko) * | 2007-09-17 | 2009-03-20 | 재단법인서울대학교산학협력재단 | 섬유증 예방 또는 치료용 약제학적 조성물 |
| AU2013262972A1 (en) * | 2012-05-16 | 2014-12-11 | Aadigen, Llc | Multi-target modulation for treating fibrosis and inflammatory conditions |
| WO2015061607A1 (fr) * | 2013-10-23 | 2015-04-30 | Whitehead Institute For Biomedical Research | Modulation de mtorc1 par acides aminés et leurs utilisations |
-
2019
- 2019-06-19 EP EP19739468.7A patent/EP3810272A1/fr not_active Withdrawn
- 2019-06-19 MA MA052960A patent/MA52960A/fr unknown
- 2019-06-19 JP JP2020570744A patent/JP2021527669A/ja not_active Withdrawn
- 2019-06-19 WO PCT/US2019/038036 patent/WO2019246298A1/fr unknown
- 2019-06-19 CN CN201980054596.4A patent/CN112839708A/zh active Pending
- 2019-06-19 US US17/254,089 patent/US20210275480A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN112839708A (zh) | 2021-05-25 |
| WO2019246298A1 (fr) | 2019-12-26 |
| EP3810272A1 (fr) | 2021-04-28 |
| US20210275480A1 (en) | 2021-09-09 |
| JP2021527669A (ja) | 2021-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA51103A (fr) | Compositions et procédés de traitement de l'atrophie musculaire et de la dystrophie myotonique | |
| MA51739A (fr) | Compositions pharmaceutiques pour le traitement de la fibrose kystique | |
| MA51306A (fr) | Compositions et procédés améliorés pour le traitement du déficit en ornithine transcarbamylase | |
| MA50849A (fr) | Substances et procédés pour le traitement d'hémoglobinopathies | |
| MA43283A (fr) | Procédés et compositions pour le traitement du cancer | |
| MA46836A (fr) | Agents, utilisations et procédés pour le traitement d'une synucléinopathie | |
| MA53873A (fr) | Compositions et procédés pour le traitement de la presbytie | |
| MA49069A (fr) | Procédés et compositions pour le traitement d'apnée du sommeil | |
| MA42439A (fr) | Agents, utilisations et procédés pour le traitement d'une synucléinopathie | |
| MA45798A (fr) | Compositions et procédés d'inhibition de masp-3 pour le traitement de maladies et troubles divers | |
| MA47719A (fr) | Esketamine pour le traitement de la dépression | |
| MA45481A (fr) | Utilisation d'exosomes pour le traitement de maladies | |
| MA54609A (fr) | Inhibiteurs aza-hétérobicycliques de mat2a et procédés d'utilisation pour le traitement du cancer | |
| MA43982A (fr) | Anticorps anti-tnf, compositions, méthodes et utilisation pour le traitement ou la prévention du diabète de type 1 | |
| MA53558A (fr) | Compositions et procédés pour le traitement d'infections virales | |
| MA54608A (fr) | Inhibiteurs aza-hétérobicycliques de mat2a et procédés d'utilisation pour le traitement du cancer | |
| MA52971A (fr) | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle | |
| MA53445A (fr) | Procédés et compositions pour la modification de plantes | |
| MA49576A (fr) | Compositions et méthodes pour le traitement d'infections fongiques | |
| MA55218A (fr) | Eskétamine pour le traitement de la dépression | |
| MA52961A (fr) | Compositions et procédés pour la réduction ou le traitement d'une inflammation | |
| MA41120A (fr) | Compositions comprenant le 15-hepe et méthodes de traitement ou de prévention de la fibrose à l'aide de celles-ci | |
| MA52960A (fr) | Compositions et procédés pour la réduction ou le traitement de la fibrose | |
| MA53741A (fr) | Procédés de traitement de troubles myéloprolifératifs | |
| MA45226A (fr) | Compositions et méthodes de traitement ou de prévention d'affections liées à l'oxalate |